Although the vaccine uses the same engineering as the one developed by Oxford/AstraZeneca but Sputnik V uses two different versions of the virus in two doses
Russia s Sputnik V vaccine 97.6% effective in real-world studyRussian scientists have found the Sputnik V vaccine 97.6% effective against COVID-19 in a real-world assessment based on data from 3.8 million people, Moscow s Gamaleya Institute and the Russian Direct Investment Fund said on Monday. The new effectiveness rate is higher than the 91.6% rate outlined in results from a large-scale trial of Sputnik V that was published in The Lancet medical journal earlier this year, and compar
8 days ago|Moscow, Russian Federation
BIAS DISTRIBUTION
4 lean
New York raises indoor venue capacity; South Africa reg... dailymaverick.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailymaverick.co.za Daily Mail and Mail on Sunday newspapers.
MOSCOW (BLOOMBERG, REUTERS) - An analysis of the 3.8 million Russians who received both Sputnik V shots between December and March showed that the vaccine has 97.6 per cent efficacy, the inoculation s state-run developers said in a statement on Monday (April 19).
The data, which compare the infection rate of people who received the shots with the incidence among the unvaccinated population, will be published in a peer-reviewed journal in May, according to the Russian Direct Investment Fund and Gamaleya National Research Centre.
The new effectiveness rate is higher than the 91.6 per cent rate outlined in results from a large-scale trial of Sputnik V and published in The Lancet medical journal earlier this year.